Skip to main content
FinSpry Logo
FinSpry
ABEO logo
ABEO
(NASDAQ)
Abeona Therapeutics Inc.
$4.82-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Abeona Therapeutics (ABEO) Stock Price & Financial Analysis

Abeona Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.50 - $4.84
52-Week High$7.54
52-Week Low$3.93
Open$4.50
Volume765.86K
Average Volume (3M)765.86K
Market Cap261.45M
Shares Outstanding54.24M
P/E Ratio (TTM)3.02
Price to Sales (P/S)621.08
Price to Book (P/B)1.45
EV/EBITDA2.06
Revenue (TTM)400.00K
Net Income (TTM)82.35M
Free Cash Flow (TTM)-82.36M
EPS (TTM)$1.52
Profit Margin20587.50%
Operating Margin-20802.25%
Return on Equity (ROE)48.09%
Debt to Equity0.12
50-Day MA$4.94
200-Day MA$5.48
52-Week Change2.92%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Last Dividend Ex-DateMar 31, 2000

Frequently Asked Questions About Abeona Therapeutics

What is the current stock price for ABEO?

As of the latest trading session, ABEO stock trades at $4.82. The 52-week range is $3.93–$7.54, with a day range of $4.50–$4.84.

What is the P/E ratio for ABEO?

Abeona Therapeutics's trailing P/E ratio is 3.0, meaning investors pay $3.0 for every $1 of annual earnings. Abeona Therapeutics operates in the Healthcare sector.

Does ABEO pay dividends?

Abeona Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ABEO?

Based on 2 analysts, the consensus for ABEO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ABEO?

Abeona Therapeutics's market capitalization is $261.4M, classifying it as a micro-cap company. Abeona Therapeutics operates in the Healthcare sector within the Biotechnology industry.